International Reference Pricing in Medicare—A Mismatch Between Policy and Evaluation

This Viewpoint explores whether savings from lower drug prices outweigh any downstream effects on manufacturer behavior, patient access, and future pharmaceutical innovation.

Authors

Institutions

Publication Details

Journal
JAMA Health Forum
Published
2026-11-13
DOI
https://doi.org/10.1001/jamahealthforum.2026.3845
Primary Topic
Pharmaceutical Economics and Policy
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

International Reference Pricing in Medicare—A Mismatch Between Policy and Evaluation

Mireille Jacobson, Darius Noshir Lakdawalla, Dana P. Goldman
3 links
JAMA Health Forum
Pharmaceutical Economics and Policy
article

International Reference Pricing in Medicare—A Mismatch Between Policy and Evaluation

Mireille Jacobson, Darius Noshir Lakdawalla, Dana P. Goldman
article en

Abstract

This Viewpoint explores whether savings from lower drug prices outweigh any downstream effects on manufacturer behavior, patient access, and future pharmaceutical innovation.

JAMA Health ForumVol. 7(11)
University of Southern California (US), University of California, Los Angeles (US)
Good health and well-being
Pharmaceutical Economics and Policy
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon